Related Experiment Video

Updated: May 29, 2026

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

Viral interference induced by live attenuated virus vaccine (OPV) can prevent otitis media

Elina Seppälä1, Hanna Viskari, Sanna Hoppu

  • 1Department of Virology, University of Tampere, Tampere, Finland. elina.m.seppala@uta.fi

Vaccine
|September 24, 2011
PubMed

Insights

Live attenuated poliovirus vaccine (OPV) may protect young children against otitis media by interfering with non-polio viruses. This finding suggests a potential dual benefit of OPV beyond polio prevention.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Vaccinology

Background:

  • Otitis media is a common childhood infection.
  • The potential for viral interference by vaccines is an area of ongoing research.
  • Live attenuated poliovirus vaccine (OPV) is widely used globally.

Purpose of the Study:

  • To investigate if OPV can reduce the incidence of otitis media in young children.
  • To determine if OPV has a clinically relevant interfering effect on non-polio infections causing otitis media.

Main Methods:

  • An open trial comparing OPV recipients (64 children) with inactivated polio vaccine (IPV) recipients (250 children).
  • Vaccination schedules included OPV at 2, 3, 6, and 12 months, and IPV at 6 and 12 months.
  • Clinical symptoms, including otitis media episodes, were monitored via questionnaires up to 24 months of age.

Main Results:

  • Fewer otitis media episodes were observed in the OPV group compared to the control group.
  • A statistically significant reduction in otitis media was noted between 6-18 months (IRR=0.76).
  • The protective effect was more pronounced in children attending daycare (IRR=0.37).

Conclusions:

  • OPV demonstrates a protective effect against otitis media in young children.
  • This protection is potentially mediated by viral interference with non-polio pathogens.
  • OPV may offer additional benefits beyond polio immunization.
Abstract

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

Related Concept Videos

Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Vaccinations01:51

Vaccinations

Overview
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...